10 Feb 2026

Strategic Foundation: Why Commercial Ready Manufacturing Should Be Considered from Day One

Name: Strategic Foundation: Why Commercial Ready Manufacturing Should Be Considered from Day One
Uploaded: 2026-03-13T18:04:00Z
Description: In a complex, volatile global market, manufacturability is no longer something to address “when the time comes”-it must be built into the therapy from day one

ElevateBio Stand: 374

View all ATW26 Content

Beyond Raw Materials: Building Partnerships That Drive Cell Therapy Innovation
Beyond Viability: Designing Cryopreservation Systems for Cell Therapy

Strategic Foundation: Why Commercial Ready Manufacturing Should Be Considered from Day One

Phacilitate’s Next Global Meeting: